Gene · 2562
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder. | Mol Genet Genomic Med | 2023 | 37186221 | PubTator, text mining | PubMed |
| GABAA Receptor β3 Subunit Mutation N328D Heterozygous Knock-in Mice Have Lennox-Gastaut Syndrome. | Int J Mol Sci | 2023 | 37176165 | PubTator, text mining | PubMed |
| Genotype-Phenotype Models Predicting V̇O 2max Response to High-Intensity Interval Training in Physically Inactive Chinese. | Med Sci Sports Exerc | 2023 | 37170954 | PubTator, text mining | PubMed |
| Genetic variations in the retrograde endocannabinoid signaling pathway in Chinese patients with major depressive disorder. | Front Neurol | 2023 | 37168668 | PubTator, text mining | PubMed |
| Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. | CNS Drugs | 2023 | 37166702 | PubTator, text mining | PubMed |
| Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. | PLoS One | 2023 | 37146093 | PubTator, text mining | PubMed |
| Loss of function of FIP200 in human pluripotent stem cell-derived neurons leads to axonal pathology and hyperactivity. | Transl Psychiatry | 2023 | 37137886 | PubTator, text mining | PubMed |
| Gamma-Aminobutyric Acid Type A Receptor Subunit Delta (GABRD) Inhibits Breast Cancer Progression by Regulating the Cell Cycle. | Iran J Public Health | 2023 | 37124892 | PubTator, text mining | PubMed |
| Latent disease similarities and therapeutic repurposing possibilities uncovered by multi-modal generative topic modeling of human diseases. | Bioinform Adv | 2023 | 37123453 | PubTator, text mining | PubMed |
| Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response. | Hum Genomics | 2023 | 37098643 | PubTator, text mining | PubMed |
| Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling. | BMC Genomics | 2023 | 37076788 | PubTator, text mining | PubMed |
| Stalled oligodendrocyte differentiation in IDH-mutant gliomas. | Genome Med | 2023 | 37055795 | PubTator, text mining | PubMed |
| Relationships between neurotransmitter receptor densities and expression levels of their corresponding genes in the human hippocampus. | Neuroimage | 2023 | 37030412 | PubTator, text mining | PubMed |
| Association of GABRG3, GABRB3, HTR2A gene variants with autism spectrum disorder. | Gene | 2023 | 37019319 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Targeted sequencing and clinical strategies in children with autism spectrum disorder: A cohort study. | Front Genet | 2023 | 37007974 | PubTator, text mining | PubMed |
| Forward Genetics-Based Approaches to Understanding the Systems Biology and Molecular Mechanisms of Epilepsy. | Int J Mol Sci | 2023 | 36982355 | PubTator, text mining | PubMed |
| Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics. | Children (Basel) | 2023 | 36980114 | PubTator, text mining | PubMed |
| GABRG2 Variants Associated with Febrile Seizures. | Biomolecules | 2023 | 36979350 | PubTator, text mining | PubMed |
| Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. | Front Genet | 2023 | 36959829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2562/papers?page=7